The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has said no to a subsidy for the obesity drug Wegovy, according to reports from multiple Swedish newspapers. The manufacturer Novo Nordisk announced this in a press release. The decision was reported by sources including Smålandsposten, Borås Tidning, Barometern-OT, BLT Blekinge Läns Tidning, Kristianstadsbladet, Vestmanlands Läns Tidning, Sundsvalls Tidning, Nerikes Allehanda, Helsingborgs Dagblad, and Skånska Dagbladet.
The reports do not specify the reasons for the rejection or provide further details on the timing or implications of the decision.